Evidence map›Paper›PMID 40653469›Full record

ArticleOrphanet journal of rare diseases2025

The influence of menstrual cycle on metabolic control and diet in patients with phenylketonuria.

Laura Horka, Kristin Landolt, Zoran Erlic, Nicole Rimann, Alessio Cremonesi, Michel Hochuli, Felix Beuschlein

Abstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Laura HorkaClinic for Endocrinology, Diabetology and clinical Nutrition, University Hospital of Zurich, Zürich, Switzerland. Laura.horka@usz.ch.ORCID http://orcid.org/0009-0009-1758-1714
Kristin LandoltDepartment of Nursing and MTTB (medical-technical and medical-therapeutic professions), University Hospital Zurich, Zürich, Switzerland.
Zoran ErlicClinic for Endocrinology, Diabetology and clinical Nutrition, University Hospital of Zurich, Zürich, Switzerland.
Nicole RimannSwiss Newborn Screening Laboratory, University Children's Hospital Zurich, University of Zurich, Zürich, Switzerland.
Alessio CremonesiSwiss Newborn Screening Laboratory, University Children's Hospital Zurich, University of Zurich, Zürich, Switzerland.
Michel HochuliDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, University Hospital Bern, Inselspital, Bern, Switzerland.
Felix BeuschleinClinic for Endocrinology, Diabetology and clinical Nutrition, University Hospital of Zurich, Zürich, Switzerland.

Funding

Danone Nutricia Research Danone Nutricia Research
6 · The paper itself

Abstract

Based on experiences from everyday clinical practice and indications from the literature, the menstrual cycle might impact on metabolic stability in patients with urea cycle disorders and organic acidurias. However, this connection has not yet been systematically investigated.Phenylketonuria (PKU) as the most prevalent inborn error of metabolism with its easily determinable biomarker is a suitable model disease to shed light on this question. In ten patients with classic PKU on a low protein diet and on an amino acid mixture, phenylalanine (Phe) was measured from dried blood spots twice a week for 6 months. During this time, the patients documented their menstrual cycle and filled in nutrition protocols since it is known that the menstrual cycle also influences nutritional behavior. Based on this cohort, we found a significant correlation between the phases of the menstrual cycle and Phe concentration, with the lowest concentrations in the early luteal phase and the highest in the early follicular phase, during menstrual bleeding. This effect did not appear to be due to a change in eating behavior, as both protein and calorie intake were not significantly different in relation to the menstrual cycle. Since the increase in Phe began before menstrual bleeding, it does also not appear to be a pure effect of catabolism due to bleeding. Further studies will be required to identify the cause of this effect and to develop possible therapeutic strategies.

Indexed as

DietMenstrual CyclePhenylketonuriasAdolescentAdultFemaleHumansPhenylalanineYoung AdultPhenylalanineCycle dependent metabolic changesMenstrual cycleNutrition therapyPhenylalaninePhenylketonuria

Identifiers

PMID40653469
PMCPMC12257650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.